BERKING BIOTECHNOLOGY
Our Company
Berking Biotechnology is a company that was born in the south of Chile, in the city of Valdivia, surrounded by lush forests, rivers and of course, surrounded by the intense Valdivian rainforest. Founded in July 2017, we are born from the idea of creating new solutions to existing problems by exploiting innovative scAb technology to facilitate research.
We work with researchers from all over the world, including countries such as Germany, Australia, South Africa, Korea, among others, being able to accredit biotechnological research at an international level, in addition to having our own range of products and services.
Our current projects include the generation of scAbs for the cell signalling and cell cycle pathways, as well as affinity based reagents. In the next years, we will be working on having our own R&D department to apply scAbs on rare diseases and aquaculture.

BERKING BIOTECHNOLOGY
Our Team
Our team is made up of expert biochemists and biotechnologists, with years of experience in the research and development of innovative technologies.

Dr. Anne Berking
General Director
Anne is one of the founders of Berking Biotechnology. She studied Biology at the University of Konstanz where she also obtained her PhD in Cell Biology. After working as a Postdoc at the University of Dundee, she started her career in the pharmaceutical sector at ProPharma Group.

Dr. Alejandro Rojas
Scientific Director
Alejandro is a co-founder of Berking Biotechnology. He studied Biotechnology at the University of Chile and earned his doctorate at the University of Konstanz. Before founding the Laboratory of Medical Biotechnology at the Austral University of Chile, he worked as a Postdoc at the University of Dundee and GlaxoSmithKline.

Paulina Cea
CFO
Paulina is Audit accountant graduated from Universidad Austral de Chile. She obtained a Bachelor of Science of Management at the École Supérieure du Commerce in Montpellier, France. She also studied a Master in Digital Marketing and E-Commerce. She currently works in the financial, administrative and accounting area of Berking Biotechnology.

Dr. Camila Navia
COO
Camila holds a PhD in Medical Sciences from Universidad Austral de Chile. She has experience managing scientific-educational initiatives and working in multidisciplinary teams with scientists from various fields. Currently, she serves as COO at Berking Biotechnology, leading initiatives that combine biotechnological innovation and strategic collaboration to develop a portfolio of products aimed at making an impact in the Latin American market.
OUR PROJECTS
Nano-SRS: Nanobodies para el tratamiento de SRS en salmones
Prv-free: tratamiento inmune pasivo contra prv basado en nanobodies para salmónidos de cultivo.
Biosensores basados en nanoanticuerpos para la vigilancia continua del riesgo de enfermedades cardiovasculares.